Holen Sie sich die Stockscreener-App
100.98
0.03%
0.03
Handel nachbörslich:
100.75
-0.23
-0.23%
Schlusskurs vom Vortag:
$100.95
Offen:
$100.96
24-Stunden-Volumen:
592.71K
Relative Volume:
1.21
Marktkapitalisierung:
$3.32B
Einnahmen:
$2.32B
Nettoeinkommen (Verlust:
$82.93M
KGV:
40.07
EPS:
2.52
Netto-Cashflow:
$203.54M
1W Leistung:
+1.70%
1M Leistung:
+3.91%
6M Leistung:
+8.84%
1J Leistung:
+2.98%
1-Tages-Spanne:
$100.73
$101.00
1-Wochen-Bereich:
$98.95
$101.01
52-Wochen-Spanne:
$82.15
$101.01
Amedisys Inc Stock (AMED) Company Profile
Firmenname
Amedisys Inc
Sektor
Branche
Telefon
(225) 292-2031
Adresse
3854 AMERICAN WAY, BATON ROUGE, LA
Vergleichen Sie AMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMED
Amedisys Inc
|
100.98 | 3.32B | 2.32B | 82.93M | 203.54M | 2.52 |
|
HCA
Hca Healthcare Inc
|
390.46 | 91.33B | 72.70B | 6.88B | 7.29B | 23.79 |
|
THC
Tenet Healthcare Corp
|
171.87 | 15.06B | 20.52B | 1.46B | 1.41B | 15.12 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.84 | 14.20B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
119.13 | 11.95B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
178.51 | 11.15B | 16.08B | 1.20B | 1.06B | 17.82 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-07 | Herabstufung | Truist | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-03-13 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-27 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-08-02 | Herabstufung | UBS | Neutral → Sell |
| 2022-06-29 | Eingeleitet | Stifel | Hold |
| 2022-06-21 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-01 | Hochstufung | UBS | Sell → Neutral |
| 2022-02-25 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-02-25 | Bestätigt | Credit Suisse | Outperform |
| 2022-02-25 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-25 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-02-25 | Bestätigt | Raymond James | Outperform |
| 2022-02-25 | Bestätigt | Truist | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Sell |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-10 | Bestätigt | The Benchmark Company | Buy |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-08-20 | Fortgesetzt | Barclays | Overweight |
| 2020-07-30 | Bestätigt | The Benchmark Company | Buy |
| 2020-06-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-05-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-03-09 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-01-17 | Eingeleitet | Credit Suisse | Outperform |
| 2019-11-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-10-22 | Fortgesetzt | Stephens | Equal-Weight |
| 2019-09-17 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-12-14 | Eingeleitet | Barclays | Equal Weight |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-10-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2018-07-03 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-03-19 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-11-09 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-11-08 | Bestätigt | Mizuho | Buy |
| 2017-11-02 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-08-21 | Eingeleitet | BofA/Merrill | Neutral |
Alle ansehen
Amedisys Inc Aktie (AMED) Neueste Nachrichten
UnitedHealth’s Amedisys acquisition to move forward after compromise with DOJ - Healthcare Brew
Can UnitedHealth Really Fight Cost Headaches With $3.3B Amedisys Pill? - MSN
What's Going On With UnitedHealth Stock Monday? - Benzinga
DOJ: UHG, Amedisys Must Divest 164 Locations for Acquisition to Proceed - Dealbreaker
Justice Department to require UnitedHealth Group divestitures in Amedisys acquisition - Financial Regulation News -
Amedisys stock reaches 52-week high at 100.99 USD By Investing.com - Investing.com Canada
Amedisys stock reaches 52-week high at 100.99 USD - Investing.com
UnitedHealth’s $3.3bn Amedisys deal faces strict divestiture terms - Yahoo Finance
Institutional Tools Highlight Unusual Flow in Amedisys Inc.Reversal Alert Based on RSI Indicator Confirmed - metal.it
DOJ Requires Broad Divestitures, $1.1M Fine To Resolve UnitedHealth-Amedisys Merger Challenge: Retail Thinks It May Reduce Expected Synergies - MSN
Maryland Among States in $3.3B UnitedHealth–Amedisys Antitrust Agreement - The MoCo Show -
Amedisys and UnitedHealth Settle with DOJ Over Acquisition - AInvest
DOJ Divestiture Remedy Opens Door for $3.3B Hospice Merger Plan Between UnitedHealth Group and Amedisys - Law.com
UnitedHealth Surges to 23rd in Trading Volume as Amedisys Acquisition Drives Home Health Industry Consolidation - AInvest
Amedisys fined $1.1 million by US DOJ for HSR Act violations - MLex
UnitedHealth Group Inc. to Divest 164 Locations in Proposed Settlement Over Amedisys Acquisition - Hoodline
Amedisys fine was less than maximum for HSR Act violations, US DOJ says (corrects*) - MLex
DOJ proposes settlement to clear way for $3.3B UnitedHealth-Amedisys deal - The Business Journals
UnitedHealth Agrees to Divest Over 160 Healthcare Facilities in $3.3B Amedisys Deal Settlement - AInvest
Why Is UnitedHealth Stock Trading Higher TodayAmedisys (NASDAQ:AMED), UnitedHealth Group (NYSE:UNH) - Benzinga
UnitedHealth, Amedisys merger appears set to close post-DOJ settlement - Healthcare Dive
O’Fallon Home Health Site Included in UnitedHealth Antitrust Divestiture - RiverBender.com
Amedisys Settles with DOJ, Shares Rise Amid Divestment and Analyst Price Predictions - AInvest
UnitedHealth's Acquisition of Amedisys: Hold Rating Maintained Amid Settlement Progress - AInvest
Justice Department Requires Broad Divestitures to Resolve Challenge to UnitedHealth’s Acquisition of Amedisys - EIN News
DOJ greenlights UnitedHealth/Amedisys with divestitures - Global Competition Review
O'Fallon Facility To Be Divested: Attorney General Raoul Announces Proposed Settlement To Resolve Challenge To UnitedHealth’s Acquisition Of Amedisys - RiverBender.com
UnitedHealth-Amedisys settlement with US DOJ requires divestitures, fine - MLex
AELP says UnitedHealth Group-Amedisys settlement a loss for hospice patients, nurses - MLex
UnitedHealth to sell off 164 locations to settle US challenge to Amedisys deal - Reuters
UnitedHealth, Amedisys Reach Settlement With DOJ Over Proposed Merger - 富途牛牛
Hold Rating Maintained Amid Settlement Progress in UnitedHealth’s Acquisition of Amedisys - TipRanks
UnitedHealth and Amedisys reach settlement with DOJ over $3.3B merger - Healthcare Dive
DOJ Oks UnitedHealth, Amedisys deal on divestiture conditions - TechTarget
UnitedHealth (UNH)-Amedisys $3.3B Merger Approved with Major DOJ Conditions - TipRanks
Amedisys shares rise 1.60% intraday after UnitedHealth and Amedisys reach settlement with DOJ. - AInvest
Justice Department Requires Broad Divestitures To Resolve Challenge To UnitedHealth's Acquisition of Amedisys - 富途牛牛
UnitedHealth to sell off 164 locations to settle US challenge to Amedisys deal | Business Information & News | FE - Westlaw Today
UnitedHealth Group, Amedisys reach merger settlement with DOJ - Modern Healthcare
UnitedHealth's Amedisys Merger: Navigating Divestitures and Shareholder Value - AInvest
Amedisys Inc and Unitedhealth agree to proposed final judgment - MarketScreener
US DOJ requires divestitures to resolve challenge to UnitedHealth’s acquisition of Amedisys - MLex
UnitedHealth to Divest 164 Facilities in Amedisys Acquisition Settlement - AInvest
[UPDATED] DOJ to Clear Way for Amedisys, UnitedHealth Group Transaction - Hospice News
DOJ to Require Broad Divestitures to Resolve Challenge to UnitedHealth's Acquisition of Amedisys - Morningstar
UnitedHealth Selling Home Health Branches In DOJ Deal - Law360
Amedisys and UnitedHealth Resolve Merger Opposition - TipRanks
Amedisys (AMED) Settles with DOJ Over $3.3 Billion UnitedHealth Deal - GuruFocus
UnitedHealth, Amedisys Reach Tentative Merger Deal With DOJ - Bloomberg.com
US Justice Dept. says broad divestitures required to resolve challenge to Unitedhealth’s acquisition of Amedisys - Reuters
[8-K] Amedisys Inc Reports Material Event | AMED SEC FilingForm 8-K - Stock Titan
Finanzdaten der Amedisys Inc-Aktie (AMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):